Title
The preventive effect of internet-based cognitive behavioral therapy for prevention of depression during pregnancy and in the postpartum period (iPDP): a large scale randomized controlled trial
Date Issued
01 January 2022
Access level
open access
Resource Type
journal article
Author(s)
Nishi D.
Imamura K.
Watanabe K.
Obikane E.
Sasaki N.
Yasuma N.
Sekiya Y.
Matsuyama Y.
Kawakami N.
Publisher(s)
John Wiley and Sons Inc
Abstract
Background: Prevention of perinatal depression beginning from the antenatal period is essential. Therefore, this study aimed to investigate the effectiveness of recently developed internet-delivered cognitive behavioral therapy (iCBT) for preventing the onset of a major depressive episode (MDE) in the third trimester and at 3 months postpartum. Methods: This is a two-arm, parallel-group, general-information controlled, randomized controlled trial. Participants were 5017 pregnant women at 16–20 weeks' gestation without MDE at baseline. They were randomly assigned to an iCBT (intervention; n = 2509) or general-information (control; n = 2508) group, stratified by psychological distress at baseline. The primary outcomes were the numbers of new MDE onsets, measured using the World Health Organization Composite International Diagnostic Interview 3.0, at 32 weeks' gestation and at 3 months postpartum. Results: New MDE onset was reported by 59 participants (2.35%) in the intervention group and 73 (2.91%) in the control group during follow-up. Compared with the control group, the hazard ratio (HR) of MDE in the intervention group was 0.85 (95% CI 0.61–1.20), which was not significantly different. Among participants who scored between 5 and 8 on K6 at baseline, 10 (1.37%) in the intervention group reported new onset of MDE, compared with 28 (3.81%) in the control group, and the HR of MDE was 0.38 (95%CI 0.19–0.79). Conclusions: No intervention effect was found for iCBT in preventing new onset of perinatal MDE. iCBT might prevent perinatal depression only among pregnant women with subthreshold depressive symptoms. Trial registration: UMIN000038190.
Language
English
OCDE Knowledge area
Psiquiatría Neurociencias
Scopus EID
2-s2.0-85138216774
PubMed ID
Source
Psychiatry and Clinical Neurosciences
ISSN of the container
13231316
Sponsor(s)
MTI Ltd. was involved in this study, as mentioned in the manuscript. Specifically, MTI Ltd. provided the author with an opportunity to recruit research participants, but no financial support was provided. The iCBT program was developed by the authors and the copyright belongs to the first author. MTI Ltd. wrote the programming code to implement the program in the app. DN reports personal fees from Startia, Inc., en‐power, Inc., MD.net , AIG General Insurance Company, Ltd., outside the submitted work. NK reports grants from Infocom Corp, Fujitsu Ltd., Fujitsu Software Technologies, and TAK Ltd., as well as personal fees from Occupational Health Foundation, Japan Dental Association, Sekisui Chemicals, Junpukai Health Care Center, Osaka Chamber of Commerce and Industry, outside the submitted work. This work was supported by a Grant‐in‐Aid for Scientific Research (A) from The Japan Society for the Promotion of Science (19H01073 to DN). The funder had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.
Sources of information: Directorio de Producción Científica Scopus